Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

CTSI nets $69.6M from NIH
August 2016
SHARING OPTIONS:

BETHESDA, Md.—The UCLA Clinical and Translational Science Institute (CTSI)—a research partnership of UCLA, Cedars-Sinai Medical Center, Charles R. Drew University of Medicine and Science and the Los Angeles Biomedical Research Institute—has been awarded $69.6 million by the National Institutes of Health (NIH), a five-year grant that will support the consortium’s ongoing development. This is the second award the institute has received from the NIH, the first being an $83.1-million Clinical and Translational Science Award in 2011. The institute’s mission is to bring biomedical innovations to bear on the greatest health needs of Los Angeles, the largest county in the country, and one of the most diverse.
 
“This funding is helping us develop new means to retain, recruit and empower scientists to work together across disciplines, departments, institutions and geography,” said Dr. Steven M. Dubinett, director of the CTSI, senior associate dean for Translational Research and associate vice chancellor for Research at the David Geffen School of Medicine at UCLA.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.